Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D Sphere Fluidics, a leading ...

CAMBRIDGE, England--(BUSINESS WIRE)--Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced ...

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect® Fc Fusion, a novel assay designed to ...

Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s development, reflecting its transition from a leading droplet-based ...

Sphere Fluidics, a leading provider of innovative droplet-based microfluidics solutions for functional profiling of single cells at scale, today announced a significant expansion of its global ...

Sphere Fluidics has launched the Cyto-Mine ® Chroma to accelerate and streamline workflows. Cyto-Mine Chroma builds on the original Cyto-Mine platform’s ability to leverage picodroplet technology to ...

Sphere Fluidics announced the launch of Cyto-Cellect ® PLUS, a fluorescence resonance energy transfer (FRET) assay to enable researchers to quantify IgG productivity with high sensitivity. The new ...

Article ‘Count’ and ‘Share’ for Sphere Fluidics Limited based on listed parameters only. The articles listed below published by authors from Sphere Fluidics Limited, organized by journal and article, ...

CAMBRIDGE, England--(BUSINESS WIRE)--Sphere Fluidics, a leading provider of innovative picodroplet-based microfluidics solutions for functional single cell analysis and isolation, today announced the ...